Comparison between Antibody Recombination and Our Recombination System

Antibody Production		E.coli Production System
VDJ Recombination	Preparation	RSS Sequence

Antibody Coding Gene Recombination, also known as V(D)J recombination, somatic recombination, is a mechanism of genetic recombination in the early stages of immunoglobulin (Ig) and T cell receptors (TCR) production of the immune system. V(D)J recombination nearly-randomly combines Variable, Diverse, and Joining gene segments of vertebrates, and because of its randomness in choosing different genes, is able to diversely encode proteins to match antigens. Our system is aiming at imitating this recombination process, using E.coli as the gene carrier. It is known to all that regional genes (V, D, J) are flanked by Recombination Signal Sequences (RSSs), and the recombination occurs when VDJ recombinase are expressed. We choose RecA enzyme to induce the recombination, while use I-Sel enzyme to cut the genome, just mimicking the process happened in B cells.

VDJ Recombination vs Lading Pad Recombination

Antibody Coding Gene Recombination, also known as V(D)J recombination, somatic recombination, is a mechanism of genetic recombination in the early stages of immunoglobulin (Ig) and T cell receptors (TCR) production of the immune system. V(D)J recombination nearly-randomly combines Variable, Diverse, and Joining gene segments of vertebrates, and because of its randomness in choosing different genes, is able to diversely encode proteins to match antigens.

When B cells develop from stem cells in the bone marrow, genes are rearranged and produce antibody that is specific for this antigen once it is recognized. The rearrangement brings together three segments (termed V, D, and J), which are spliced together in a process that is appropriately named V(D)J recombination. V(D)J recombination is an important source of antibody diversity, since the V(D)J segment is the part of the antibody that recognizes antigen. There are multiple copies of the V, D, and J genes in the human genome, and a functioning antibody will be one of over a million possible combinations. The final sequence is permanently spliced together so that a mature B cell will produce only one specific antibody.

Our system is aiming at imitating this recombination process, using E.coli as the gene carrier. It is known to all that regional genes (V, D, J) are flanked by Recombination Signal Sequences (RSSs), and the recombination occurs when VDJ recombinase are expressed. We choose RecA enzyme to induce the recombination, while use I-Sel enzyme to cut the genome, just mimicking the process happened in B cells. Besides, the Landing Pad Sequence acts just as the RSSs do.

Somatic hyper-mutation vs Junctional mutation

Somatic hypermutation involves a programmed process of mutation affecting the variable regions of immunoglobulin genes. During proliferation, the B cell receptor locus undergoes an extremely high rate of somatic mutation that is at least 105-106 fold greater than the normal rate of mutation across the genome. Variation is mainly in the form of single base substitutions, with insertions and deletions being less common. These mutations occur mostly at “hotspots” in the DNA, known as hypervariable regions. These regions correspond to the complementarity determining regions; the sites involved in antigen recognition on the immunoglobulin. This directed hypermutation allows for the selection of B cells that express immunoglobulin receptors possessing an enhanced ability to recognize and bind a specific foreign antigen.

In addition, the cross ligation, namely Landing pad recombination, has higher opportunity to mutate in the link sequence. The introduction of 4 junctional shuffler 64 will meet the need of the rest 107 diversity, perfectly undertaking the work in the antibody diversity construction that hyper-mutation does in the highly variable region. In this way, we have finished a building library, waiting for the specialized antigen to select.

Antigen-specific Selection vs CBD-Based Microarray and ToxR-Based Transmembrane pathway method

The antibodies that a B cell produces will then, naturally, bind to the antigen for which they are specific, blocking viruses or bacteria from infecting cells and marking these foreign invaders for destruction by macrophages. This natural process is convinced by the final immune response.

We don’t have the real immune procedure to find out our antibody, but some fantastic proteins and pathways help us to achieve the same result. When the library builds, we have two modules to select and test the very E.coli which produces the antibody we need. Using the CBD binding domain and OmpA presenting domain, we are hopingly able to utilize the microarray method to select our aimed antibody.

The CBD binding domain, which interacts with cellulose, potentially provides us way to locate our E.coli to the fibers. Then, the OmpA protein, belonging to the Omp presentation protein family, brings antibody to the outer membrane, expecting antigen to bind.

In the other hand, the ToxR-based transmembrane pathway method shows a different strategy for us to seek the right folded antibody. Once the antigen comes, ToxR outer part will form dimer shape and the downstream signal occur, supplying the approach of reporters, such as GFP, to examine and pick out what we want.

More Amazing at Module 1
More Amazing at Module 2    TOP